Flutterby™! : Ivermectin still not effective for COVID

Next unread comment / Catchup all unread comments User Account Info | Logout | XML/Pilot/etc versions | Long version (with comments) | Weblog archives | Site Map | | Browse Topics

Ivermectin still not effective for COVID

2024-11-18 17:25:22.775534+01 by Dan Lyke 0 comments

JAMA Editor's Note: At a Higher Dose and Longer Duration, Ivermectin Still Not Effective Against COVID-19 doi:10.1001/jama.2023.1922

Cochrane meta-analysis of 11 eligible trials examining the efficacy of ivermectin for the treatment of COVID-19 published through April 2022 concluded that ivermectin has no beneficial effect for people with COVID-19.

And that this has been found again (and again, and again), and that there are still trials recruiting participants for studies is raising questions about ethics in medical research. The Ethics of Clinical Research — Managing Persistent Uncertainty.

University of Minnesota Center for Infections Disease Research and Policy: Higher ivermectin dose, longer duration still futile for COVID, trial finds

[ related topics: Ethics Education ]

comments in descending chronological order (reverse):

Comment policy

We will not edit your comments. However, we may delete your comments, or cause them to be hidden behind another link, if we feel they detract from the conversation. Commercial plugs are fine, if they are relevant to the conversation, and if you don't try to pretend to be a consumer. Annoying endorsements will be deleted if you're lucky, if you're not a whole bunch of people smarter and more articulate than you will ridicule you, and we will leave such ridicule in place.


Flutterby™ is a trademark claimed by

Dan Lyke
for the web publications at www.flutterby.com and www.flutterby.net.